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Abstract The cell cycle control phosphatases Cdc25 are dual
specificity phosphatases that dephosphorylate both phospho-
threonine and phosphotyrosine residues on their substrate
proteins. The determination of the apo-protein structure of
Cdc25A revealed that this enzyme has a completely different fold
compared to all other phosphatases crystallised to date. The
conformation of the active site residues does not seem very
suitable for catalysis in this unliganded structure. We have
studied some structural features of the Cdc25A apo-structure and
a modelled Cdc25A-ligand complex by molecular dynamics
simulations. The simulations predict a conformational change in
the peptide backbone of the complex, which is not observed in the
apo-structure. This ligand-induced conformational change yields
a structure that is similar to other protein tyrosine phosphatase-
ligand complexes that have been crystallised. The change in
conformation takes place in the position between a serine and a
glutamic acid residue in the phosphate binding loop. We suggest
that this type of conformational change is an important
molecular switch in the catalytic process.
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1. Introduction
Cdc25 is a family of dual speci¢city protein phosphatases
(DSPs) involved in the regulation of the eukaryotic cell cycle.
The Cdc25 proteins dephosphorylate the cyclin dependent
kinases which are thereby activated and can ensure the cell
correct timing for transition into the next phase of the cycle
[1]. There are three cloned isoforms of Cdc25 in human and
mammals, Cdc25A, B and C. The isoforms have high se-
quence identity, especially in the active site region, but are
presumed to be active in di¡erent phases of the cell cycle
[2]. For example, Cdc25A is found to be expressed during
the G1CS transition [3,4], whereas Cdc25B and Cdc25C
are thought to regulate the entry into the mitotic phase [5].
Cdc25 proteins have an active site motif that is typical for
phosphotyrosine speci¢c protein tyrosine phosphatases (PTPs)
as well as VH1 like DSPs. These enzymes all contain the
characteristic H-C-X5-R motif, which encompasses the nucle-
ophilic cysteine and the arginine involved in substrate binding
and transition state stabilisation. The backbone of the ¢ve
residues between Cys and Arg forms the phosphate binding
cradle supplying a network of hydrogen bonds to the phos-
phate moiety of the substrate. The common active site motif
of these enzymes suggests that they all employ the same mech-
anism for catalysis. The catalysed reaction has been shown to
proceed via a two-step pathway where the nucleophilic cys-
teine is phosphorylated in the ¢rst step [6]. As the leaving
group is protonated by an assisting general acid, the ¢rst
product, the dephosphorylated tyrosyl/seryl/threonyl residue,
is released. The phosphocysteine intermediate is subsequently
hydrolysed by an activated water molecule in the second step
of the reaction.
The recently published crystal structure of Cdc25A revealed
that this enzyme has a completely di¡erent fold than the other
PTPs, and has an identical topology to that of rhodanese, a
sulfur transfer protein [7]. Although di¡erent in fold, the crys-
tal structure con¢rms the expected features of the character-
istic active site. There are, however, a few discrepancies be-
tween Cdc25 and the PTPs that are worth mentioning. The
Cdc25 proteins do not have serine or threonine immediately
after the active site arginine. In the other PTPs and DSPs, the
hydroxyl group of this residue is proposed to stabilise the
ionised form of the nucleophilic cysteine during catalysis.
Here, one of the serines (Ser-433) in the phosphate binding
loop is proposed to accomplish this stabilisation instead [7].
Another di¡erence is the fact that no auxiliary loop contain-
ing a catalytic general acid residue is observed in Cdc25. The
general acid has been shown to be very important for enhanc-
ing the rate of phosphomonoester hydrolysis in the PTPs.
Eckstein et al. [8] suggested from mutational experiments
and sequence alignments that the conserved Asp-383 could
be the general acid residue. However, this hypothesis did
not hold when the crystal structure was determined. Asp-83
forms an ion pair inside the protein and is probably conserved
to maintain the correct structure. Interpretations of the crystal
structure suggested that Glu-431 is suitably positioned in the
active site loop and may therefore function as the general acid
[7]. This Glu is also totally conserved throughout the Cdc25
family.
The crystal structure of Cdc25A was determined in absence
of an inhibitor or substrate analogue in the active site. This
resulted in an open conformation with the arginine side-chain
in a position that would not be optimal for transition state
stabilisation. Furthermore, the backbone of the phosphate
binding loop is found in an unexpected conformation. In or-
der to study some structural aspects of Cdc25, we performed
molecular dynamics (MD) simulations of the Cdc25A apo-
structure and a modelled Cdc25A-sulfate ion complex.
2. Materials and methods
All MD simulations were run using the software package Q [9]
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together with the GROMOS87 force ¢eld [10]. The initial protein
coordinates were taken from the crystal structure of Cdc25A, PDB
accession code 1C25 [7]. The active site of the enzyme was solvated by
a 16 Aî sphere of SPC water molecules. The solvent surface was sub-
jected to radial and polarisational restraints as described in [9]. Pro-
tein atoms outside the simulation sphere were restrained to their crys-
tallographic coordinates and interacted only via bonds, angles and
torsions across the boundary. The system was heated to a temperature
of 300 K by a stepwise equilibration protocol where the protein atoms
were restrained to their initial coordinates. After the heating proce-
dure, the restraints were turned o¡ and MD was run at constant
temperature 300 K with a time step of 1 fs. The trajectories of the
apo-structure were run straightforwardly, whereas the initial structure
of the Cdc25-ligand complex was obtained by a few minor structural
modi¢cations. The crystal structure of the low molecular weight PTP
in complex with sulfate [11] (PDB entry 1PHR) was used as a tem-
plate for the modelling. The backbone atoms of the loop residues
430^436 in Cdc25 and 12^18 in the low molecular weight PTP were
superimposed (Fig. 1A). The resulting position of the sulfate ion was
then transferred to the corresponding coordinates in the Cdc25 struc-
ture. The torsional angles of the Arg-436 side-chain were modi¢ed so
that the guanidinium group interacted with two of the sulfate oxy-
gens, similar to the binding mode found in all other crystallised PTP-
ligand complexes. To avoid clashes, the side-chains of Glu-431 and
Phe-432 were also slightly moved.
3. Results
The MD trajectories of the apo-structure in water were run
for 65 ps at 300 K and showed relatively stable energies and
well retained structures. Simulation of the modelled complex
of Cdc25A and SO234 yielded stable trajectories after 2.5 ps
simulation at 300 K. However, already at 2 ps, a conforma-
tional change in the backbone peptide bond between residue
Ser-434 and Glu-435 occurred. In the starting (crystal) struc-
ture, the dipoles of this peptide bond are ‘inverted’ compared
to the pattern seen in the other H-C-X5-R containing struc-
tures. ‘Inverted’ here refers to the fact that the carbonyl oxy-
gen is pointing into the phosphate binding site and the amide
nitrogen is pointing outwards. This conformation would be
electrostatically unfavourable when there is a negatively
charged substrate bound in the phosphate binding loop and
thus the dipoles £ip over to the preferred conformation when
the sulfate ion is present (Fig. 1B). The conformational
change was clearly monitored by measuring the Ramachan-
dran angles of residues Ser-434 and Glu-435 during the MD
trajectory (Fig. 2). The diagram shows that residue 435 has a
strained conformation in the starting structure with the Ra-
machandran angles B and i being unstable and located out-
side the allowed regions. As the trajectory proceeds, the
torsional angle B changes and the Ramachandran trajectory
ends up in the allowed region of the diagram. For Ser-434,
mainly the i angle changes its value and the Ramachandran
plot trajectory is displaced from the allowed region de¢ned by
L-structures into the region typical for K-helical structures.
The sulfate ion in the active site was replaced by a phenyl
phosphate molecule in a new set of MD simulations. The
average structures showed that the phenyl ring preferably in-
teracts with the side-chain of F432, which has been proposed
to be important for phosphotyrosine recognition [7]. In this
binding mode, where the two phenyl rings stack with each
other, Glu-431 does not appear to be in a proper position
for proton donation to the bridging oxygen of the substrate.
The side-chain of Glu-431 is also surrounded by basic residues
which would not stabilise the protonated form of the glutamic
acid required for catalysis in other PTPs. As far as stabilisa-
tion of the nucleophilic cysteine is concerned, the simulations
showed that Ser-433 is able to interact with the ionised sulfur
atom, although they are quite distant in the crystal structure
(4.6 Aî ). However, the interaction is not very stable and the
hydroxyl group of the serine residue rather interacts with the
carbonyl oxygen of Leu-465 (2.8 Aî apart in the crystal struc-
ture) during most parts of the trajectory.
Fig. 1. A: Superposition of the backbone atoms of residues 430^436
in Cdc25A (white, PDB entry 1C25) and 12^18 in low molecular
weight PTP (grey, PDB entry 1PHR). The sulfate ion is found in
the crystal structure 1PHR. In addition to Ser-434 and Glu-435,
only the totally conserved side-chains Cys and Arg are shown for
clarity. B: Average MD structure of the ligand complex with
Cdc25A after the observed conformational change, superimposed on
low molecular weight PTP as in A.
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4. Discussion
All crystal structures of PTPs and DSPs in complex with
various ligands have a common structure of the active site
with the backbone amides of the loop residues pointing into
the centre of the crevice in order to stabilise the equatorial
oxygens of the phosphomimetic group. The conformation of
the corresponding region in the structure of Cdc25A, where
one of the peptide bonds is pointing its amide group in the
opposite direction, has not been observed before. This con-
formation would be very disfavoured in the enzyme-substrate
complex with the negatively charged phosphate group posi-
tioned in the binding loop. It would also have a destabilising
e¡ect on the transition state which requires maximal stabilisa-
tion of the equatorial oxygens for e⁄cient catalysis.
In this work, we have studied the e¡ect of docking an oxy-
anion in the active site of Cdc25A. By running MD simula-
tions of the modelled complex, we found that the whole pep-
tide bond spontaneously £ips so as to stabilise the substrate/
product analogue. The result is not totally unexpected, but
may have interesting implications. It may indicate that also
other conformational changes occur upon substrate binding,
for instance, the side-chain conformations of Ser-434 and Glu-
435. It is thus possible that the observed conformational
change is a mechanism to orient these residues in favourable
positions for catalysis or substrate recognition. This would
then be similar to the ligand-induced loop closure that occurs
in, for example, PTP1B. It is tempting to propose that Glu-
435 could act as a general acid as it comes closer to the active
site upon this conformational change. However, mutation of
the corresponding residue in Cdc25B yielded an enzyme with
similar activity as the wild-type [12].
Cdc25A is similar to the low molecular weight PTP in that
there is an additional cysteine residue that appears able to
form a disul¢de bridge with the catalytic cysteine under cer-
tain conditions [7,13]. In the latter case, this residue (reduced
Cys-17) has been proposed to play a role in the hydrolysis of
the phosphoenzyme intermediate by interaction with the water
nucleophile [14]. However, in Cdc25A, the non-catalytic cys-
teine (Cys-384) is located in a position where such a function
could not be accomplished.
The general acid found in all tyrosine speci¢c phosphatases
and VH1 like DSPs has not yet been unambiguously identi¢ed
in Cdc25. The absolutely conserved Glu-431 is a good candi-
date. However, its position and local environment in our en-
zyme-substrate model do not seem optimal for this function.
The side-chain would have to adopt a strained conformation
in order to reach the bridging oxygen of the substrate, since
the Arg-436 side-chain displaces Glu-431 from its crystallo-
graphic position. Site-directed mutagenesis is required to an-
swer the question regarding the importance of this residue. It
has been reported that replacement of the ¢ve amino acids
between the active site cysteine and arginine (Glu-Phe-Ser-Ser-
Glu) with (Ser-Ala-Gly-Val-Gly) completely abolishes activity
[15]. However, this could be due to other e¡ects than the lack
of a general acid residue. In the case of Cdc25, it cannot be
excluded that the enzyme actually functions without such a
general acid group. The turnover rate of Cdc25 with pNPP as
substrate is generally so low that it is comparable to the rate
of a PTP with the general acid mutated [16^18]. The unusually
shallow binding site in Cdc25 makes the leaving group more
solvent accessible compared to the case in, for example, the
low molecular weight PTP which is narrow and hydrophobic
in this region [11,19]. E⁄cient solvation of the leaving group
by water molecules instead of using a general acid for proto-
nating the leaving group might be su⁄cient for catalysis in
this case. Further biochemical investigations and structural
studies of Cdc25 complexes should hopefully be able to clarify
the detailed action of this important enzyme family.
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